Post
Post

IncomeSharks / ARTICLE

Genomes and Insider Buying Activity This is a slower moving industry that had an early genetic hype bubble pop that now actually gets more attractive when the processing power, chips, and memory can start to handle the input/output of gene sequencing and finding theraputic solutions. $WSG - Huge earnings miss that led to a 50% sell off that led to 85 million in insider buying and has since almost fully retraced that. A drop like that triggers an automatic SEC investigation but the insiders seem like they know it was just panic selling. Almost reminds me of $GRAL where it had a huge drop then has been working to erase it. Sellers are very emotional in the bio tech world where the high beta swings are crazy. $CRSP - Being patient on this one but if they can deliver which looks like they will it's got some great upside potential. The mistake most will make on this one is wanting instant gains and not focusing on a 1 to 4 time frame. Genetics moves slow until suddenly it doesn't with a giant break through or commercialization of a gene editing therapeutic drug. Look at $LLY and how explosive GLP-1s became. This is the upside potential I'm willing to risk to chase but trying to remain patient with entries where maybe one entry a month kind of thing to stay level headed and not over analyze prices. Call activity for other related Genome stocks $TXG - $285k - $40 $WGS - $53.5k - $55 $ADPT - $50k - $20 $TWST - $40.2k - $72.5 $NTRA - $33k - $260

Published Jun 10, 2026Updated Jun 10, 20264 min read
Genomes and Insider Buying Activity This is a slower moving industry that had an early genetic hype bubble pop that now actually gets more attractive when the processing power, chips, and memory can start to handle the input/output of gene sequencing and finding theraputic solutions. $WSG - Huge earnings miss that led to a 50% sell off that led to 85 million in insider buying and has since almost fully retraced that. A drop like that triggers an automatic SEC investigation but the insiders seem like they know it was just panic selling. Almost reminds me of $GRAL where it had a huge drop then has been working to erase it. Sellers are very emotional in the bio tech world where the high beta swings are crazy. $CRSP - Being patient on this one but if they can deliver which looks like they will it's got some great upside potential. The mistake most will make on this one is wanting instant gains and not focusing on a 1 to 4 time frame. Genetics moves slow until suddenly it doesn't with a giant break through or commercialization of a gene editing therapeutic drug. Look at $LLY and how explosive GLP-1s became. This is the upside potential I'm willing to risk to chase but trying to remain patient with entries where maybe one entry a month kind of thing to stay level headed and not over analyze prices. Call activity for other related Genome stocks $TXG - $285k - $40 $WGS - $53.5k - $55 $ADPT - $50k - $20 $TWST - $40.2k - $72.5 $NTRA - $33k - $260